These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 27189281)

  • 1. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
    Cazzo E; Jimenez LS; Gestic MA; Utrini MP; Chaim FHM; Chaim FDM; Pareja JC; Chaim EA
    Obes Surg; 2018 Jan; 28(1):187-194. PubMed ID: 28741239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement.
    Huang Z; Ng K; Chen H; Deng W; Li Y
    Front Endocrinol (Lausanne); 2021; 12():739875. PubMed ID: 35173677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
    Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
    J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
    Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
    Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The impact of non-alcoholic fatty liver disease on islet function in type 2 diabetes].
    Yan L; Wang S; Fu Y; Wang X; Zheng X; Zheng Y; Liu X
    Zhonghua Nei Ke Za Zhi; 2015 Mar; 54(3):197-200. PubMed ID: 26269440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control.
    Patel PJ; Hossain F; Horsfall LU; Banh X; Hayward KL; Williams S; Johnson T; Brown NN; Saad N; Valery PC; Irvine KM; Clouston AD; Stuart KA; Russell AW; Powell EE
    J Diabetes Complications; 2018 Aug; 32(8):799-804. PubMed ID: 29861312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes.
    El-Ashmawy HM; Ahmed AM
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):859-864. PubMed ID: 30601337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
    Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
    Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure.
    Misan IA; Arisheva OS; Garmash IV; Cabello FR; Kobalava ZD
    Kardiologiia; 2023 Dec; 63(12):72-76. PubMed ID: 38156493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload.
    Altamura S; Müdder K; Schlotterer A; Fleming T; Heidenreich E; Qiu R; Hammes HP; Nawroth P; Muckenthaler MU
    Mol Metab; 2021 Sep; 51():101235. PubMed ID: 33872860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients.
    Mansour A; Mohajeri-Tehrani MR; Samadi M; Gerami H; Qorbani M; Bellissimo N; Poustchi H; Hekmatdoost A
    Acta Diabetol; 2019 Nov; 56(11):1199-1207. PubMed ID: 31197470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.
    Hazim A; Purnamasari D; Kalista KF; Lesmana CRA; Nugroho P
    Diabetes Metab Syndr; 2019; 13(2):1431-1435. PubMed ID: 31336502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.
    Targher G; Mantovani A; Grander C; Foco L; Motta B; Byrne CD; Pramstaller PP; Tilg H
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3464-3473. PubMed ID: 34627696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease.
    Yamasandhi PG; Dharmalingam M; Balekuduru A
    Indian J Gastroenterol; 2021 Dec; 40(6):556-562. PubMed ID: 34950996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.